The Korea Disease Control and Prevention Agency (KDCA) began implementing infectious disease countermeasures three weeks ahead of schedule on Friday, in response to a rapid rise in norovirus and other respiratory illnesses.
The government is gearing up to roll out public health measures to combat the “twindemic” of mycoplasma pneumonia and influenza.
Pyongyang entered a five-day lockdown on Wednesday to combat a rise in cases of respiratory illness, according to an official North Korean government notice seen by NK News.
More people are coming down with flu-like symptoms, health officials announced Sunday, raising concerns of a “twindemic” — when seasonal influenza and the coronavirus circulate simultaneously.
GC LabCell won approval to start Phase 1 clinical trials of CT303, its treatment candidate for acute respiratory distress syndrome (ARDS).
Korea JoongAng Daily Sitemap
